CSTL vs EIX · rev $332.1M vs P/E 7.3, rev $17.60B
Castle Biosciences Inc (CSTL) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CSTL revenue for 2024-12-31 was $332.1M. Net income was $18.2M. Revenue was up 51.1% from 2023-12-31 to 2024-12-31. CSTL currently screens at market cap $570.2M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CSTL currently screens at market cap $570.2M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CSTL and EIX stock pages for the full models.
Not investment advice.